Literature DB >> 12706303

Anti-androgenic properties of Compound A, an analog of a non-steroidal plant compound.

T M Tanner1, G Verrijdt, W Rombauts, A Louw, J P Hapgood, F Claessens.   

Abstract

We investigated the interactions between Compound A (CpdA), an analog of a hydroxyphenyl aziridine precursor found in an African shrub, and the androgen receptor (AR). CpdA represses androgen-induced activation of both specific and non-specific androgen DNA response elements. While a similar effect was obtained for the progesterone receptor (PR) via a non-specific hormone response element, CpdA had no effect on the actions of the glucocorticoid and mineralocorticoid receptors. CpdA represses the ligand-dependent interaction between the NH(2)- and COOH-terminal domains of the AR, similar to well-characterised anti-androgens. CpdA also interferes with the interaction of steroid receptor co-activator 1 (SRC1) with the activation domain AF2 but not with AF1. However, CpdA does not compete with androgen for binding to the AR. These results demonstrate that CpdA elicits anti-androgenic actions by a mechanism other than competitive binding for the AR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706303     DOI: 10.1016/s0303-7207(02)00411-2

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  10 in total

Review 1.  Phytosteroids beyond estrogens: Regulators of reproductive and endocrine function in natural products.

Authors:  Matthew Dean; Brian T Murphy; Joanna E Burdette
Journal:  Mol Cell Endocrinol       Date:  2016-12-13       Impact factor: 4.102

2.  Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.

Authors:  Alexander Yemelyanov; Pankaj Bhalla; Ximing Yang; Andrey Ugolkov; Kenichi Iwadate; Apollon Karseladze; Irina Budunova
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth.

Authors:  Maria Papaioannou; Sonja Schleich; Daniela Roell; Undine Schubert; Tamzin Tanner; Frank Claessens; Rudolf Matusch; Aria Baniahmad
Journal:  Invest New Drugs       Date:  2009-09-23       Impact factor: 3.850

4.  Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis.

Authors:  Simone Wüst; Denise Tischner; Michael John; Jan P Tuckermann; Christiane Menzfeld; Uwe-Karsten Hanisch; Jens van den Brandt; Fred Lühder; Holger M Reichardt
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

5.  Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.

Authors:  Yichun Zheng; Hitoshi Ishiguro; Hiroki Ide; Satoshi Inoue; Eiji Kashiwagi; Takashi Kawahara; Mehrsa Jalalizadeh; Leonardo O Reis; Hiroshi Miyamoto
Journal:  Mol Endocrinol       Date:  2015-08-31

6.  Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a.

Authors:  Steven Robertson; Fatima Allie-Reid; Wim Vanden Berghe; Koch Visser; Anke Binder; Donita Africander; Michael Vismer; Karolien De Bosscher; Janet Hapgood; Guy Haegeman; Ann Louw
Journal:  J Biol Chem       Date:  2009-12-26       Impact factor: 5.157

Review 7.  Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity.

Authors:  Ekaterina Lesovaya; Alexander Yemelyanov; Amanda C Swart; Pieter Swart; Guy Haegeman; Irina Budunova
Journal:  Oncotarget       Date:  2015-10-13

Review 8.  Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments.

Authors:  Nora Sundahl; Dorien Clarisse; Marc Bracke; Fritz Offner; Wim Vanden Berghe; Ilse M Beck
Journal:  Oncoscience       Date:  2016-07-27

9.  GR-independent down-modulation on GM-CSF bone marrow-derived dendritic cells by the selective glucocorticoid receptor modulator Compound A.

Authors:  Andres E Barcala Tabarrozzi; Luz Andreone; Julie Deckers; Carla N Castro; María L Gimeno; Laura Ariolfo; Paula M Berguer; María Antunica-Noguerol; Ana C Liberman; Sabine Vettorazzi; Jan P Tuckermann; Karolien De Bosscher; Marcelo J Perone
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

Review 10.  The Role of Glucocorticoid Receptor Signaling in Bladder Cancer Progression.

Authors:  Hiroki Ide; Satoshi Inoue; Hiroshi Miyamoto
Journal:  Cancers (Basel)       Date:  2018-12-04       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.